1047. Weight change associated with switching to bictegravir/emtricitabine/tenofovir alafenamide in virally suppressed people with HIV

BACKGROUND: Integrase strand transfer inhibitor (INSTI) associated weight gain has been observed in a number of recent studies but with limited data on bictegravir. Here we examine weight change associated with the switch to co-formulated bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF). ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Vo, Daniel, Goss, Charles W, Lian, Qinghua, O’Halloran, Jane A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777652/
http://dx.doi.org/10.1093/ofid/ofaa439.1233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777652/
http://dx.doi.org/10.1093/ofid/ofaa439.1233

Ejemplares similares